Causality here is argued by convergence of manipulations that a confounded correlation could not survive. (1) Necessity: germ-free mice and antibiotic-pretreated mice make no d9-TMAO from labelled oral choline/PC, and conventionalization restores it — so gut flora are an obligate step. (2) Necessity for disease, not just for the metabolite: antibiotics that drop plasma TMAO >100-fold also abolish the ~3-fold choline-induced atherosclerosis and the macrophage/CD36 increase, tying the disease effect specifically to the flora-generated metabolite rather than to choline per se. (3) Sufficiency: feeding TMAO itself (bypassing the choline→TMA step) reproduces the atherosclerosis, and it does so with no rise in plasma cholesterol, triglycerides, or glucose — excluding the classical lipid pathway as the mediator. (4) A mechanistic handle: choline/TMAO/betaine upregulate macrophage scavenger receptors CD36 and SR-A and drive foam-cell formation, supplying a plausible cellular route from TMAO to plaque. (5) An independent, non-dietary line: in an F2 genetic cross, host hepatic FMO3 (which oxidizes TMA to TMAO) co-segregates with lesion area and plasma TMAO (and inversely with HDL), so genetic variation that changes TMAO changes atherosclerosis without any dietary manipulation — a mendelian-randomization-flavoured corroboration. No single line is decisive, but necessity + sufficiency + mechanism + genetics pointing the same way is the signature of a causal pathway rather than a shared-confounder correlation. Scope caveat: all of this is in Apoe-/- mice, an accelerated-atherosclerosis model, so it licenses the pathway’s existence and causal direction in mice, not automatically its magnitude in humans.
Validity (step 6)
status: approved, reason_if_not_false: checked.
The step is elementary experimental causal logic (necessity + sufficiency + a genetic instrument), traceable without specialist formalism, so checked and author-blind. Assuming the observations (O-32–O-36), the word “establish … in mice” is warranted because the design contains genuine do-operations at both ends of the chain, not just correlation:
- Necessity of the whole flora step: germ-free/antibiotic mice make no labelled TMAO from choline; conventionalization restores it. Necessity for disease: antibiotics that drop TMAO >100-fold also abolish the choline-induced atherosclerosis — tying the disease to the flora-made metabolite, not to choline per se.
- Sufficiency: feeding TMAO directly (bypassing the choline→TMA step) reproduces atherosclerosis, and does so with no lipid/glucose change — which closes the main alternative mediator (lipids) and pins the effect on TMAO itself.
- The obvious defeater to a pure-necessity argument — antibiotics abolishing disease via some non-TMAO microbiome effect — is killed by the sufficiency arm (TMAO alone suffices). Reverse causation is killed by the FMO3 F2-cross genetics (host genotype that raises TMAO raises plaque, with no dietary manipulation).
Necessity and sufficiency established by intervention jointly span the chain and survive the standard confounder/reverse-causation defeaters, so “establish a causal chain in mice” holds as stated. The claim is explicitly scoped to mice (existence/direction, not human magnitude), so it does not over-reach. Approved.